# US 2006/0068387 A1 · Genetic marker for endocrine disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0068387 A1
- Document ID: US20060068387A1
- Status: Published application
- Kind: A1
- Application number: 10/511,710
- Filed: 2003-04-22
- Published: 2006-03-30
- Earliest claimed: 2002-04-22
- Assignees: Northwestern University
- Inventors: Andrea Dunaif
- Web page: https://patentgrep.com/patent/US20060068387A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C07K 14/47: from mammals
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A genetic marker associated with polycystic ovary syndrome is disclosed. The presence or absence of the allele is highly predictive of whether an individual is at risk from polycystic ovary syndrome. Methods of diagnosis, markers, and primers are disclosed and claimed in accordance with the present invention.

## Claims

### Claim 1

A method to determine the presence or absence of polycystic ovary syndrome (PCOS) in an individual, comprising:
a) providing DNA or RNA from the individual; and
b) assessing the DNA or RNA for the presence or absence of the PCOS-associated allele A8(+) of a base pair polymorphism designated herein D19S884; wherein, as a result, the absence of the allele indicates a likely absence of a PCOS causative gene in the genome of the individual and the presence of the allele a likely presence of the PCOS causative gene in the genome of the individual.

### Claim 2 (depends on 1)

The method of claim 1, wherein the assessing step is performed by a process that comprises subjecting the DNA or RNA to amplification using oligonucleotide primers flanking at least a portion of D19S884.

### Claim 3 (depends on 1)

The method of claim 1, further comprising the step of treating said individual to prevent or ameliorate PCOS.

### Claim 4

A kit for the detection of the presence or absence of a PCOS-associated allele of D19S884 comprising reagents for detecting said allele and instructions for correlating the presence or absence of said allele to a medical intervention.
